Literature DB >> 20961972

Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis.

Gregory Levin1, Bryan Kestenbaum, Yii-Der Ida Chen, David R Jacobs, Bruce M Psaty, Jerome I Rotter, David S Siscovick, Ian H de Boer.   

Abstract

Diabetes mellitus and hypertension commonly coexist, but the nature of this link is not well understood. The authors tested whether diabetes and higher concentrations of fasting serum glucose and insulin are associated with increased risk of developing incident hypertension in the community-based Multi-Ethnic Study of Atherosclerosis. At baseline, 3,513 participants were free of hypertension, defined as systolic blood pressure ≥140 mm Hg, diastolic blood pressure ≥90 mm Hg, or use of antihypertensive medications to treat high blood pressure. Of these, 965 participants (27%) developed incident hypertension over 4.7 years' median follow-up between 2002 and 2007. Compared with participants with normal baseline fasting glucose, those with impaired fasting glucose and diabetes had adjusted relative risks of hypertension of 1.16 (95% confidence interval (CI): 0.96, 1.40) and 1.41 (95% CI: 1.17, 1.71), respectively (P = 0.0015). The adjusted relative risk of incident hypertension was 1.08 (95% CI: 1.04, 1.13) for each mmol/L higher glucose (P < 0.0001) and 1.15 (95% CI: 1.05, 1.25) for each doubling of insulin (P = 0.0016). Further adjustment for serum cystatin C, urinary albumin/creatinine ratio, and arterial elasticity measured by tonometry substantially reduced the magnitudes of these associations. In conclusion, diabetes and higher concentrations of glucose and insulin may contribute to the development of hypertension, in part through kidney disease and arterial stiffness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961972      PMCID: PMC3004765          DOI: 10.1093/aje/kwq266

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  32 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

3.  Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.

Authors:  E Coll; A Botey; L Alvarez; E Poch; L Quintó; A Saurina; M Vera; C Piera; A Darnell
Journal:  Am J Kidney Dis       Date:  2000-07       Impact factor: 8.860

4.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

Authors:  A C Guyton; T G Coleman; A V Cowley; K W Scheel; R D Manning; R A Norman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

5.  Coincident linkage of fasting plasma insulin and blood pressure to chromosome 7q in hypertensive hispanic families.

Authors:  L S Cheng; R C Davis; L J Raffel; A H Xiang; N Wang; M Quiñones; P Z Wen; E Toscano; J Diaz; S Pressman; P C Henderson; S P Azen; W A Hsueh; T A Buchanan; J I Rotter
Journal:  Circulation       Date:  2001-09-11       Impact factor: 29.690

6.  Evidence for joint genetic control of insulin sensitivity and systolic blood pressure in hispanic families with a hypertensive proband.

Authors:  A H Xiang; S P Azen; L J Raffel; S Tan; L S Cheng; J Diaz; E Toscano; P C Henderson; H N Hodis; W A Hsueh; J I Rotter; T A Buchanan
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

7.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

8.  Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure.

Authors:  Jørgen V Bjørnholt; Gunnar Erikssen; Sverre E Kjeldsen; Johan Bodegård; Erik Thaulow; Jan Erikssen
Journal:  J Hypertens       Date:  2003-07       Impact factor: 4.844

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Cystatin C improves the detection of mild renal dysfunction in older patients.

Authors:  Shelagh E O'Riordan; Michelle C Webb; Helen J Stowe; David E Simpson; Madhu Kandarpa; Anthony J Coakley; David J Newman; Jean A Saunders; Edmund J Lamb
Journal:  Ann Clin Biochem       Date:  2003-11       Impact factor: 2.057

View more
  23 in total

1.  Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year.

Authors:  Christianne L Roumie; Xulei Liu; Neesha N Choma; Robert A Greevy; Adriana M Hung; Carlos G Grijalva; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-03-19       Impact factor: 2.890

2.  Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: Toranomon hospital health management center study 16 (TOPICS 16).

Authors:  Y Heianza; Y Arase; S Kodama; S D Hsieh; H Tsuji; K Saito; S Hara; H Sone
Journal:  J Hum Hypertens       Date:  2014-09-18       Impact factor: 3.012

3.  Glucose and the risk of hypertension in first-degree relatives of patients with type 2 diabetes.

Authors:  Mohsen Janghorbani; Fabrice Bonnet; Masoud Amini
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

4.  Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population.

Authors:  B Arshi; M Tohidi; A Derakhshan; S Asgari; F Azizi; F Hadaegh
Journal:  J Hum Hypertens       Date:  2014-08-28       Impact factor: 3.012

5.  Association between changes in systolic blood pressure and incident diabetes in a community-based cohort study in Korea.

Authors:  Seung Won Lee; Hyeon Chang Kim; Ju-Mi Lee; Young Mi Yun; Joo Young Lee; Il Suh
Journal:  Hypertens Res       Date:  2017-03-02       Impact factor: 3.872

6.  Type 2 Diabetes and Hypertension.

Authors:  Dianjianyi Sun; Tao Zhou; Yoriko Heianza; Xiang Li; Mengyu Fan; Vivian A Fonseca; Lu Qi
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

7.  Diet pattern may affect fasting insulin in a large sample of black and white adults.

Authors:  Barbara A Gower; Keith Pearson; Nikki Bush; James M Shikany; Virginia J Howard; Caroline W Cohen; Stephanie E Tison; George Howard; Suzanne Judd
Journal:  Eur J Clin Nutr       Date:  2020-10-06       Impact factor: 4.016

8.  Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Pengcheng Xun; Ying Wu; Qianchuan He; Ka He
Journal:  Am J Clin Nutr       Date:  2013-10-16       Impact factor: 7.045

9.  Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging.

Authors:  Alexander C Razavi; Tanika N Kelly; Matthew J Budoff; Lydia A Bazzano; Jiang He; Camilo Fernandez; Joao Lima; Khurram Nasir; Roger S Blumenthal; Michael J Blaha; Seamus P Whelton
Journal:  Atherosclerosis       Date:  2021-03-26       Impact factor: 5.162

10.  Hypertension and type 2 diabetes: lights and shadows about causality.

Authors:  GianLuca Colussi; Andrea Da Porto; Alessandro Cavarape
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.